Gene patents face Supreme Court reckoning

| January 2, 2013 |
Supreme_Court_of_the_United_States

Medical-testing companies differ on the potential impact of the Supreme Court ruling on the Myriad Genetics BRCA1 patent. Many companies offer a range of tests. Figuring out who owns the rights to all those genes isn’t easy.

View the original article here: Gene Patents Face Reckoning